DexCom Financials
| DC4 Stock | 78.36 0.11 0.14% |
DexCom |
Understanding current and past DexCom Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DexCom's financial statements are interrelated, with each one affecting the others. For example, an increase in DexCom's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in DexCom's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DexCom Inc. Check DexCom's Beneish M Score to see the likelihood of DexCom's management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | US2521311074 |
| Benchmark | Dow Jones Industrial |
You should never invest in DexCom without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of DexCom Stock, because this is throwing your money away. Analyzing the key information contained in DexCom's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
DexCom Key Financial Ratios
DexCom's financial ratios allow both analysts and investors to convert raw data from DexCom's financial statements into concise, actionable information that can be used to evaluate the performance of DexCom over time and compare it to other companies across industries.DexCom Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DexCom's current stock value. Our valuation model uses many indicators to compare DexCom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DexCom competition to find correlations between indicators driving DexCom's intrinsic value. More Info.DexCom Inc is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in price to book category among its peers . The ratio of Current Valuation to Price To Book for DexCom Inc is about 1,632,533,712 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DexCom's earnings, one of the primary drivers of an investment's value.DexCom Inc Systematic Risk
DexCom's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DexCom volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on DexCom Inc correlated with the market. If Beta is less than 0 DexCom generally moves in the opposite direction as compared to the market. If DexCom Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DexCom Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DexCom is generally in the same direction as the market. If Beta > 1 DexCom moves generally in the same direction as, but more than the movement of the benchmark.
DexCom January 7, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of DexCom help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DexCom Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of DexCom Inc based on widely used predictive technical indicators. In general, we focus on analyzing DexCom Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DexCom's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.39 | |||
| Information Ratio | 0.2105 | |||
| Maximum Drawdown | 9.94 | |||
| Value At Risk | (2.13) | |||
| Potential Upside | 3.69 |
Additional Tools for DexCom Stock Analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.